Bentham Science Logo

Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 19, 8 Issues, 2019
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access

Contents

Endocrine, Metabolic & Immune Disorders - Drug Targets, Volume 9 - Number 1









Methodologic Issues in the Validation of Putative Biomarkers and Surrogate Endpoints in Treatment Evaluation for Systemic Lupus Erythematosus

, 9(1): 108 - 112

Matthew H. Liang, Julia F. Simard, Karen Costenbader, Benjamin T. Dore, Michael Ward, Paul R. Fortin, Gabor G. Illei, Susan Manzi, Barbara Mittleman, Jill Buyon, Samardeep Gupta and Michal Abrahamowicz


DOI: 10.2174/187153009787582388




Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
Italy

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.
Track Your Manuscript:


Scopus CiteScore Metrics: 1.93



Related Journals

Related eBooks

eBooks Catalog